These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38487137)

  • 1. Protective Effect of Ferulic Acid on Acetylcholinesterase and Amyloid Beta Peptide Plaque Formation in Alzheimer's Disease: An In Vitro Study.
    Mugundhan V; Arthanari A; Parthasarathy PR
    Cureus; 2024 Feb; 16(2):e54103. PubMed ID: 38487137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Potential of Ferulic Acid in Alzheimer's Disease.
    Turkez H; Arslan ME; Barboza JN; Kahraman CY; de Sousa DP; Mardinoğlu A
    Curr Drug Deliv; 2022; 19(8):860-873. PubMed ID: 34963433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease.
    Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G
    Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant and Cholinesterase Inhibitory Activities of Ethyl Acetate Extract of
    Rajmohamed MA; Natarajan S; Palanisamy P; Abdulkader AM; Govindaraju A
    Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S437-S445. PubMed ID: 29142396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
    Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
    Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Properties of Ferulic Acid in Preclinical Models of Alzheimer's Disease: A Systematic Literature Review.
    Zhou S; Dong X
    Curr Med Chem; 2023; 30(24):2796-2811. PubMed ID: 36065925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boron Nitride Nanoparticles Loaded with a Boron-Based Hybrid as a Promising Drug Carrier System for Alzheimer's Disease Treatment.
    Yıldırım ÖÇ; Arslan ME; Öner S; Cacciatore I; Di Stefano A; Mardinoglu A; Turkez H
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholinesterase (AChE)--amyloid-beta-peptide complexes in Alzheimer's disease. the Wnt signaling pathway.
    Inestrosa NC; Urra S; Colombres M
    Curr Alzheimer Res; 2004 Nov; 1(4):249-54. PubMed ID: 15975054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Synthetic Pro-Drug Peptide Reverses Amyloid-β-Induced Toxicity in the Rat Model of Alzheimer's Disease.
    Kumar S; Srivastav S; Fatima M; Giri RS; Mandal B; Mondal AC
    J Alzheimers Dis; 2019; 69(2):499-512. PubMed ID: 30958369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706.
    Carvajal FJ; Inestrosa NC
    Front Mol Neurosci; 2011; 4():19. PubMed ID: 21949501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel inhibitors of AChE and Aβ aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease.
    Liu Y; Uras G; Onuwaje I; Li W; Yao H; Xu S; Li X; Li X; Phillips J; Allen S; Gong Q; Zhang H; Zhu Z; Liu J; Xu J
    Eur J Med Chem; 2022 May; 235():114305. PubMed ID: 35339839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-bisabolol β-D-fucopyranoside as a potential modulator of β-amyloid peptide induced neurotoxicity: An in vitro &in silico study.
    Jeyakumar M; Sathya S; Gandhi S; Tharra P; Suryanarayanan V; Singh SK; Baire B; Pandima Devi K
    Bioorg Chem; 2019 Jul; 88():102935. PubMed ID: 31030060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Multifunctional 5,6-Dimethoxy-Indanone-Chalcone-Carbamate Hybrids Alleviates Cognitive Decline in Alzheimer's Disease by Dual Inhibition of Acetylcholinesterase and Inflammation.
    Liu C; Sang Z; Pan H; Wu Q; Qiu Y; Shi J
    Front Aging Neurosci; 2022; 14():922650. PubMed ID: 35860673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
    Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
    Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Neuroprotective Peptide Emerged from Dual Neurotherapeutic Targets: A Fusion Approach for the Development of Anti-Alzheimer's Lead.
    Mondal P; Das G; Khan J; Pradhan K; Mallesh R; Saha A; Jana B; Ghosh S
    ACS Chem Neurosci; 2019 May; 10(5):2609-2620. PubMed ID: 30840820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of quinazolinone and vanillin acrylamide hybrids as multi-target directed ligands against Alzheimer's disease and mechanistic insights into their binding with acetylcholinesterase.
    Yelamanda Rao K; Jeelan Basha S; Monika K; Naidu Gajula N; Sivakumar I; Kumar S; Vadde R; Aramati BMR; Subramanyam R; Damu AG
    J Biomol Struct Dyn; 2023 Dec; 41(20):11148-11165. PubMed ID: 37098803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydrohyperforin decreases cholinergic markers associated with amyloid-β plaques, 4-hydroxynonenal formation, and caspase-3 activation in AβPP/PS1 mice.
    Carvajal FJ; Zolezzi JM; Tapia-Rojas C; Godoy JA; Inestrosa NC
    J Alzheimers Dis; 2013; 36(1):99-118. PubMed ID: 23568104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholinesterase-amyloid-beta-peptide interaction: effect of Congo Red and the role of the Wnt pathway.
    Inestrosa NC; Alvarez A; Dinamarca MC; Pérez-Acle T; Colombres M
    Curr Alzheimer Res; 2005 Jul; 2(3):301-6. PubMed ID: 15974895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.